SCHEMBL15075433

SCHEMBL15075433

COc1cnc(-c2cc(C3CC3)n(Cc3ccccc3)n2)nc1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ PRCP P42785 1/20 0.39
▸ PDE4A P27815 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ SLC2A1 P11166 1/20 0.39
▸ RET P07949 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ STAT3 P40763 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GALR3 O60755 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ NPY1R P25929 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15075441 0.91 ADORA2A (0.39) ADORA2A
SCHEMBL15075439 0.82 SMN1; SMN2 (0.40) ADORA2ASMN1; SMN2PDE4APDE4BPDE4C
SCHEMBL15060027 0.81 BUB1 (0.55) —
SCHEMBL17481625 0.73 KDM4E (0.44) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL15075373 0.70 GUCY1B2 (0.53) —
SCHEMBL15075440 0.70 GUCY1B2 (0.51) —
SCHEMBL15055475 0.70 BUB1 (0.43) MEN1KMT2A
SCHEMBL15056092 0.69 NPC1 (0.37) ADORA2ASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL15075434 0.68 GUCY1B2 (0.51) —
SCHEMBL15075371 0.67 BUB1 (0.45) SMN1; SMN2MAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794596-B1 SUBSTITUTED BENZYLPYRAZOLES BAYER IP GMBH (DE) 2017-05-31 — — EP disclosed
EP-2794596-B1 SUBSTITUTED BENZYLPYRAZOLES BAYER IP GMBH (DE) 2017-05-31 — — EP disclosed
US-9643953-B2 Substituted benzylpyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-05-09 — — US disclosed
US-9643953-B2 Substituted benzylpyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-05-09 — — US disclosed
US-9643953-B2 Substituted benzylpyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-05-09 — — US disclosed
US-9422268-B2 — — 2016-08-23 — — US disclosed
US-9422268-B2 — — 2016-08-23 — — US disclosed
US-9422268-B2 — — 2016-08-23 — — US disclosed
US-20140315934-A1 SUBSTITUTED BENZYLPYRAZOLES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-23 — — US disclosed
US-20140315934-A1 SUBSTITUTED BENZYLPYRAZOLES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-23 — — US disclosed
US-20140315934-A1 SUBSTITUTED BENZYLPYRAZOLES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-23 — — US disclosed
WO-2013092512-A1 SUBSTITUTED BENZYLPYRAZOLES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-06-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140315934-A1 SUBSTITUTED BENZYLPYRAZOLES CYP3A43, CYP3A7, ABCB1 ADORA2A 2822/4885SMN1; SMN2 1800/4885PRCP 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback